Jefferies Maintains Buy on Tenet Healthcare, Lowers Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Brian Tanquilut has maintained a Buy rating on Tenet Healthcare (NYSE:THC) but has reduced the price target from $95 to $85.

November 14, 2023 | 7:14 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Jefferies analyst maintains a Buy rating on Tenet Healthcare but lowers the price target from $95 to $85, indicating a positive outlook but with tempered expectations.
While the Buy rating reaffirms confidence in Tenet Healthcare's fundamentals and potential growth, the reduction in price target suggests that there may be factors that could limit the stock's upside in the short term. This could lead to a neutral short-term impact as the market digests both the continued endorsement and the lowered expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100